Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2013; 19(29): 4745-4751
Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4745
Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4745
OSA group (n = 31) | Control group (n =65) | P value | |
Patient characteristics | |||
Age (yr) | 51.3 ± 9.6 | 47.1 ± 11.8 | 0.082 |
Sex (male) | 23 (74.2) | 27 (41.5) | 0.003 |
Height (meters) | 167.1 ± 6.8 | 164.4 ± 8.0 | 0.104 |
Weight (kg) | 74.3 ± 11.2 | 62.6 ± 12.0 | 0.000 |
BMI (kg/m2) | 26.5 ± 3.0 | 23.1 ± 3.3 | 0.000 |
Smoking | 9 (29.0) | 9 (13.8) | 0.075 |
Drinking | 11 (35.5) | 24 (36.9) | 0.891 |
Charlson score (points) | 1.0 ± 0.2 | 1.0 ± 0.0 | 0.325 |
Hypertension | 10 (32.3) | 9 (13.8) | 0.034 |
Diabetes mellitus | 4 (12.9) | 7 (10.8) | 0.759 |
Baseline clinical data | |||
Systolic BP (mmHg) | 127.6 ± 16.9 | 114.3 ± 22.2 | 0.004 |
Diastolic BP (mmHg) | 79.3 ± 10.6 | 66.1 ± 14.4 | 0.000 |
SaO2 (%) | 97.6 ± 1.7 | 98.0 ± 2.2 | 0.418 |
OSA group (n = 31) | Control group (n = 65) | P value | |
EGD data | |||
Duration of EGD (s) | 261.4 ± 79.6 | 304.4 ± 154.2 | 0.074 |
Midazolam dosage (mg) | 5.3 ± 0.9 | 4.5 ± 0.8 | 0.000 |
MOAA/S score (points, at 2 min) | 2.5 ± 1.2 | 2.9 ± 1.0 | 0.146 |
Level of sedation for EGD | 0.024 | ||
Moderate sedation | 13 (41.9) | 43 (66.2) | |
Deep sedation | 18 (58.1) | 22 (33.8) | |
Adverse events | |||
Sedation failure | 0 (0.0) | 0 (0.0) | - |
Paradoxical responses | 4 (12.9) | 4 (6.2) | 0.268 |
Snoring or apnea | 5 (16.1) | 7 (10.8) | 0.458 |
Hypoxia (SaO2 < 90%) | 1 (3.2) | 7 (10.8) | 0.211 |
Hypotension | 0 (0.0) | 0 (0.0) | - |
Other adverse events | 0 (0.0) | 0 (0.0) | - |
Oxygen administration | 1 (3.2) | 1 (0.2) | 0.588 |
Flumazenil administration | 0 (0.0) | 0 (0.0) | - |
Parameter | OR (95%CI) | P value |
Age (continuous) | 1.056 (0.958-1.164) | 0.276 |
Sex (female vs male) | 1.003 (0.153-6.563) | 0.997 |
Smoking (no vs yes) | 0.753 (0.056-10.127) | 0.830 |
Alcohol (no vs yes) | 0.592 (0.095-3.706) | 0.576 |
Diabetes mellitus (no vs yes) | 1.842 (0.187-18.128) | 0.601 |
Hypertension (no vs yes) | 1.102 (0.120-10.117) | 0.932 |
Body mass index (< 25 kg/m2vs≥ 25 kg/m2) | 1.304 (0.192-8.845) | 0.786 |
Midazolam dose (< 5 mg vs≥ 5 mg) | 10.726 (0.815-141.100) | 0.071 |
OSA (no vs yes) | 0.117 (0.012-1.168) | 0.068 |
- Citation: Cha JM, Jeun JW, Pack KM, Lee JI, Joo KR, Shin HP, Shin WC. Risk of sedation for diagnostic esophagogastroduodenoscopy in obstructive sleep apnea patients. World J Gastroenterol 2013; 19(29): 4745-4751
- URL: https://www.wjgnet.com/1007-9327/full/v19/i29/4745.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i29.4745